BioSpace News Archive

HUTCHMED Limited will be announcing its interim results for the six months ended June 30, 2021 on Wednesday, July 28, 2021 at 12:00 noon British Summer Time ; 7:00 am Eastern Daylight Time ).

MISSISSAUGA, ON, July 2, 2021 /PRNewswire/ - Covalon Technologies Ltd., an advanced medical technologies company, announced the results of the matters voted upon at its Fiscal 2020 Annual and Special Meeting of Shareholders held June 30th, 2021.

On April 30th, SonoScape received the CE-marking, the product’s “Passport to Europe”, for its linear-array echoendoscope EG-UC5T. This further expands SonoScape’s endoscopic ultrasound (EUS) portfolio in the international market

ObsEva SA announced the presentation of clinical data from the PROLONG Phase 2a proof-of-concept study of ebopiprant, an oral prostaglandin F2alpha antagonist, for the treatment of spontaneous preterm labor at the Society for Reproductive Investigation 68th Annual Meeting, being held virtually and in Boston July 6 -9, 2021.

Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, announced that second quarter of fiscal year 2021 financial results will be reported after the market closes on Monday, August 9th.

Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (ALS), today announced the appointment of Jan Hillson, M.D., to the company’s Board of Directors.

The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH